GNPX

Genprex Inc. Common Stock (GNPX)

Stock · NASDAQ · Health Care

$2.11as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 3, 2026

GNPX Among Top Movers in Monday After-Hours Session. Genprex (GNPX) was listed among the top gainers and losers in Monday's after-hours trading, according to market trackers. This movement places the stock in focus within the broader health care sector's post-market activity. The company's stock is currently trading near its 52-week low, with technical indicators showing oversold conditions.

Active signals

Resistance level
$3.84
Industry
Biotechnology: Pharmaceutical Preparations

What GNPX's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Bollinger Band Breakdown24-9.9%42%
Bollinger Band Breakout14-31.0%21%
Volume Spike11-19.7%18%
200-Day Moving Average TouchActive now3-22.2%0%
Any 20-session window (baseline)-17.3%22%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About GNPX

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company's technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes. Its oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-bas…

Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Employees
13

Fundamentals

1-day range
$2.65$2.93
Market cap
$2.24M
P/E (trailing)
—
P/E (forward)
-1.25
EPS (trailing)
$-173.01
Dividend yield
—
Beta
-0.96
Avg. volume
250.5K
52-week range
$2.53$1,210

Genprex Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • GNPX
    Genprex Inc. Common Stock
    $2.11
    ▼ 7.86%
    Market cap $2.24MP/E —
    $2.53$1,210
  • PPBT
    Purple Biotech Ltd. American Depositary Shares
    $1.14
    ▼ 7.32%
    Market cap $2.29MP/E —
    $1$2.2
  • AZTR
    Azitra Inc Common Stock
    $0.072
    ▲ 0.00%
    Market cap $2.18MP/E 6.22
    $0.0518$1.09
  • DCOY
    Decoy Therapeutics Inc. Common Stock
    $1.17
    ▼ 4.88%
    Market cap $2.40MP/E —
    $2.01$55.92
  • SXTC
    China SXT Pharmaceuticals Inc. Class A Ordinary Shares
    $0.065
    ▼ 5.80%
    Market cap $2.06MP/E —
    $0.0619$83,758
  • BFRGW
    Bullfrog AI Holdings Inc. Warrants
    $0.13
    ▲ 25.85%
    Market cap $2.04MP/E —
    $0.0751$0.6488
  • OGEN
    Oragenics Inc. Common Stock
    $0.43
    ▼ 2.27%
    Market cap $2.45MP/E 0.56
    $0.43$1.45

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
0
Disposed
18

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.